Investment Summary |
|
|---|---|
| Date | 2006-01-02 |
| Target | ARMGO Pharma |
| Sector | Life Science |
| Investor(s) | Aisling Capital |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 1.8B USD |
| Size | Large |
| Type | Sector Focused |
Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 56 |
| Sector: Life Science M&A | 3 of 42 |
| Type: Venture M&A Deals | 3 of 29 |
| State: New York M&A | 1 of 7 |
| Country: United States M&A | 4 of 52 |
| Year: 2006 M&A | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-07-18 |
Xanodyne Pharmaceuticals
Newport, Kentucky, United States Xanodyne Pharmaceuticals is a fully integrated, branded specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women?s health and pain management. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-06-01 |
Archimica
Origgio, Virginia, United States Archimica is a privately held pharmaceutical fine chemical company that combines world-scale chemical manufacturing experience with a history of pharmaceutical commercialization that stretches back over 40 years. |
Buy | - |
